Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

A genetically encoded fluorescent sensor for in vivo imaging of GABA.

Marvin JS, Shimoda Y, Magloire V, Leite M, Kawashima T, Jensen TP, Kolb I, Knott EL, Novak O, Podgorski K, Leidenheimer NJ, Rusakov DA, Ahrens MB, Kullmann DM, Looger LL.

Nat Methods. 2019 Jul 15. doi: 10.1038/s41592-019-0471-2. [Epub ahead of print]

PMID:
31308547
2.

AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.

Salpietro V, Dixon CL, Guo H, Bello OD, Vandrovcova J, Efthymiou S, Maroofian R, Heimer G, Burglen L, Valence S, Torti E, Hacke M, Rankin J, Tariq H, Colin E, Procaccio V, Striano P, Mankad K, Lieb A, Chen S, Pisani L, Bettencourt C, Männikkö R, Manole A, Brusco A, Grosso E, Ferrero GB, Armstrong-Moron J, Gueden S, Bar-Yosef O, Tzadok M, Monaghan KG, Santiago-Sim T, Person RE, Cho MT, Willaert R, Yoo Y, Chae JH, Quan Y, Wu H, Wang T, Bernier RA, Xia K, Blesson A, Jain M, Motazacker MM, Jaeger B, Schneider AL, Boysen K, Muir AM, Myers CT, Gavrilova RH, Gunderson L, Schultz-Rogers L, Klee EW, Dyment D, Osmond M, Parellada M, Llorente C, Gonzalez-Peñas J, Carracedo A, Van Haeringen A, Ruivenkamp C, Nava C, Heron D, Nardello R, Iacomino M, Minetti C, Skabar A, Fabretto A; SYNAPS Study Group, Raspall-Chaure M, Chez M, Tsai A, Fassi E, Shinawi M, Constantino JN, De Zorzi R, Fortuna S, Kok F, Keren B, Bonneau D, Choi M, Benzeev B, Zara F, Mefford HC, Scheffer IE, Clayton-Smith J, Macaya A, Rothman JE, Eichler EE, Kullmann DM, Houlden H.

Nat Commun. 2019 Jul 12;10(1):3094. doi: 10.1038/s41467-019-10910-w.

3.

Novel therapies for epilepsy in the pipeline.

Mesraoua B, Deleu D, Kullmann DM, Shetty AK, Boon P, Perucca E, Mikati MA, Asadi-Pooya AA.

Epilepsy Behav. 2019 Jul 5;97:282-290. doi: 10.1016/j.yebeh.2019.04.042. [Epub ahead of print] Review.

PMID:
31284159
4.

Editorial.

Kullmann DM.

Brain. 2019 Jun 1;142(6):1489-1490. doi: 10.1093/brain/awz135. No abstract available.

PMID:
31135047
5.

Designer receptor technology for the treatment of epilepsy.

Lieb A, Weston M, Kullmann DM.

EBioMedicine. 2019 May;43:641-649. doi: 10.1016/j.ebiom.2019.04.059. Epub 2019 May 9. Review.

6.

Editorial.

Kullmann DM.

Brain. 2019 May 1;142(5):1165. doi: 10.1093/brain/awz110. No abstract available.

PMID:
31032847
7.

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.

Weston M, Kaserer T, Wu A, Mouravlev A, Carpenter JC, Snowball A, Knauss S, von Schimmelmann M, During MJ, Lignani G, Schorge S, Young D, Kullmann DM, Lieb A.

Sci Adv. 2019 Apr 17;5(4):eaaw1567. doi: 10.1126/sciadv.aaw1567. eCollection 2019 Apr.

8.

Hippocampal-prefrontal coherence mediates working memory and selective attention at distinct frequency bands and provides a causal link between schizophrenia and its risk gene GRIA1.

Bygrave AM, Jahans-Price T, Wolff AR, Sprengel R, Kullmann DM, Bannerman DM, Kätzel D.

Transl Psychiatry. 2019 Apr 18;9(1):142. doi: 10.1038/s41398-019-0471-0.

9.

Editorial.

Kullmann DM.

Brain. 2019 Apr 1;142(4):833. doi: 10.1093/brain/awz077. No abstract available.

PMID:
30946476
10.

Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment.

Salpietro V, Malintan NT, Llano-Rivas I, Spaeth CG, Efthymiou S, Striano P, Vandrovcova J, Cutrupi MC, Chimenz R, David E, Di Rosa G, Marce-Grau A, Raspall-Chaure M, Martin-Hernandez E, Zara F, Minetti C; Deciphering Developmental Disorders Study; SYNAPS Study Group, Bello OD, De Zorzi R, Fortuna S, Dauber A, Alkhawaja M, Sultan T, Mankad K, Vitobello A, Thomas Q, Mau-Them FT, Faivre L, Martinez-Azorin F, Prada CE, Macaya A, Kullmann DM, Rothman JE, Krishnakumar SS, Houlden H.

Am J Hum Genet. 2019 Apr 4;104(4):721-730. doi: 10.1016/j.ajhg.2019.02.016. Epub 2019 Mar 28.

11.

KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition.

Magloire V, Cornford J, Lieb A, Kullmann DM, Pavlov I.

Nat Commun. 2019 Mar 15;10(1):1225. doi: 10.1038/s41467-019-08933-4.

12.

Editorial.

Kullmann DM.

Brain. 2019 Mar 1;142(3):489. doi: 10.1093/brain/awz028. No abstract available.

PMID:
30810214
13.

Epilepsy Gene Therapy Using an Engineered Potassium Channel.

Snowball A, Chabrol E, Wykes RC, Shekh-Ahmad T, Cornford JH, Lieb A, Hughes MP, Massaro G, Rahim AA, Hashemi KS, Kullmann DM, Walker MC, Schorge S.

J Neurosci. 2019 Apr 17;39(16):3159-3169. doi: 10.1523/JNEUROSCI.1143-18.2019. Epub 2019 Feb 12.

14.

Editorial.

Kullmann DM.

Brain. 2018 Mar 1;141(3):621. doi: 10.1093/brain/awy038. No abstract available.

PMID:
30753415
15.

Editorial.

Kullmann DM.

Brain. 2019 Feb 1;142(2):227. doi: 10.1093/brain/awy350. No abstract available.

PMID:
30698761
16.

Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities.

Stewart M, Lau P, Banks G, Bains RS, Castroflorio E, Oliver PL, Dixon CL, Kruer MC, Kullmann DM, Acevedo-Arozena A, Wells SE, Corrochano S, Nolan PM.

Dis Model Mech. 2019 Feb 22;12(2). pii: dmm036806. doi: 10.1242/dmm.036806.

17.

Gene-Environment Interaction in a Conditional NMDAR-Knockout Model of Schizophrenia.

Bygrave AM, Masiulis S, Kullmann DM, Bannerman DM, Kätzel D.

Front Behav Neurosci. 2019 Jan 10;12:332. doi: 10.3389/fnbeh.2018.00332. eCollection 2018.

18.

Editorial.

Kullmann DM.

Brain. 2019 Jan 1;142(1):1. doi: 10.1093/brain/awy321. No abstract available.

PMID:
30596908
19.

Editorial.

Kullmann DM.

Brain. 2018 Dec 1;141(12):3279. doi: 10.1093/brain/awy295. No abstract available.

PMID:
30496364
20.

Semiology, clustering, periodicity and natural history of seizures in an experimental occipital cortical epilepsy model.

Chang BL, Leite M, Snowball A, Lieb A, Chabrol E, Walker MC, Kullmann DM, Schorge S, Wykes RC.

Dis Model Mech. 2018 Dec 14;11(12). pii: dmm036194. doi: 10.1242/dmm.036194.

21.

Editorial.

Kullmann DM.

Brain. 2018 Nov 1;141(11):3083. doi: 10.1093/brain/awy268. No abstract available.

PMID:
30364980
22.

Analogue closed-loop optogenetic modulation of hippocampal pyramidal cells dissociates gamma frequency and amplitude.

Nicholson E, Kuzmin DA, Leite M, Akam TE, Kullmann DM.

Elife. 2018 Oct 23;7. pii: e38346. doi: 10.7554/eLife.38346.

23.

GABAergic Interneurons in Seizures: Investigating Causality With Optogenetics.

Magloire V, Mercier MS, Kullmann DM, Pavlov I.

Neuroscientist. 2018 Oct 15:1073858418805002. doi: 10.1177/1073858418805002. [Epub ahead of print]

PMID:
30317911
24.

Editorial.

Kullmann DM.

Brain. 2018 Sep 1;141(9):2533. doi: 10.1093/brain/awy227. No abstract available.

PMID:
30169592
25.

Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms.

Wolff AR, Bygrave AM, Sanderson DJ, Boyden ES, Bannerman DM, Kullmann DM, Kätzel D.

Sci Rep. 2018 Aug 27;8(1):12871. doi: 10.1038/s41598-018-31163-5.

26.

Editorial.

Kullmann DM.

Brain. 2018 Aug 1;141(8):2231. doi: 10.1093/brain/awy201. No abstract available.

PMID:
30060020
27.

Editorial.

Kullmann DM.

Brain. 2018 Jul 1;141(7):1887. doi: 10.1093/brain/awy166. No abstract available.

PMID:
30053177
28.

Biochemical autoregulatory gene therapy for focal epilepsy.

Lieb A, Qiu Y, Dixon CL, Heller JP, Walker MC, Schorge S, Kullmann DM.

Nat Med. 2018 Sep;24(9):1324-1329. doi: 10.1038/s41591-018-0103-x. Epub 2018 Jul 9.

29.

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.

Codner GF, Mianné J, Caulder A, Loeffler J, Fell R, King R, Allan AJ, Mackenzie M, Pike FJ, McCabe CV, Christou S, Joynson S, Hutchison M, Stewart ME, Kumar S, Simon MM, Agius L, Anstee QM, Volynski KE, Kullmann DM, Wells S, Teboul L.

BMC Biol. 2018 Jun 21;16(1):70. doi: 10.1186/s12915-018-0530-7.

30.

Editorial.

Kullmann DM.

Brain. 2018 May 1;141(5):1235. doi: 10.1093/brain/awy106. No abstract available.

PMID:
29701792
31.

Spider toxin inhibits gating pore currents underlying periodic paralysis.

Männikkö R, Shenkarev ZO, Thor MG, Berkut AA, Myshkin MY, Paramonov AS, Kulbatskii DS, Kuzmin DA, Sampedro Castañeda M, King L, Wilson ER, Lyukmanova EN, Kirpichnikov MP, Schorge S, Bosmans F, Hanna MG, Kullmann DM, Vassilevski AA.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4495-4500. doi: 10.1073/pnas.1720185115. Epub 2018 Apr 10.

32.

The Enlightened Brain: Novel Imaging Methods Focus on Epileptic Networks at Multiple Scales.

Rossi LF, Kullmann DM, Wykes RC.

Front Cell Neurosci. 2018 Mar 26;12:82. doi: 10.3389/fncel.2018.00082. eCollection 2018.

33.

Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.

Männikkö R, Wong L, Tester DJ, Thor MG, Sud R, Kullmann DM, Sweeney MG, Leu C, Sisodiya SM, FitzPatrick DR, Evans MJ, Jeffrey IJM, Tfelt-Hansen J, Cohen MC, Fleming PJ, Jaye A, Simpson MA, Ackerman MJ, Hanna MG, Behr ER, Matthews E.

Lancet. 2018 Apr 14;391(10129):1483-1492. doi: 10.1016/S0140-6736(18)30021-7. Epub 2018 Apr 5.

34.

Editorial.

Kullmann DM.

Brain. 2018 Apr 1;141(4):935. doi: 10.1093/brain/awy074. No abstract available.

PMID:
29596669
35.

Pathogenic potential of antibodies to the GABAB receptor.

Nibber A, Mann EO, Pettingill P, Waters P, Irani SR, Kullmann DM, Vincent A, Lang B.

Epilepsia Open. 2017 Jul 19;2(3):355-359. doi: 10.1002/epi4.12067. eCollection 2017 Sep.

36.

Imaging pathological activities of human brain tissue in organotypic culture.

Le Duigou C, Savary E, Morin-Brureau M, Gomez-Dominguez D, Sobczyk A, Chali F, Milior G, Kraus L, Meier JC, Kullmann DM, Mathon B, de la Prida LM, Dorfmuller G, Pallud J, Eugène E, Clemenceau S, Miles R.

J Neurosci Methods. 2018 Mar 15;298:33-44. doi: 10.1016/j.jneumeth.2018.02.001. Epub 2018 Feb 7.

37.

Editorial.

Kullmann DM.

Brain. 2018 Feb 1;141(2):323. doi: 10.1093/brain/awx368. No abstract available.

PMID:
29390125
38.

Editorial.

Kullmann DM.

Brain. 2018 Jan 1;141(1):1. doi: 10.1093/brain/awx345. No abstract available.

PMID:
29325050
39.

Editorial.

Kullmann DM.

Brain. 2017 Jul 1;140(7):1817. doi: 10.1093/brain/awx159. No abstract available.

PMID:
29177499
40.

Editorial.

Kullmann DM.

Brain. 2016 Nov 1;139(11):2815. doi: 10.1093/brain/aww265. No abstract available.

PMID:
29106490
41.

Editorial.

Kullmann DM.

Brain. 2017 Nov 1;140(11):2763. doi: 10.1093/brain/awx268. No abstract available.

PMID:
29088351
42.

Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.

Manole A, Jaunmuktane Z, Hargreaves I, Ludtmann MHR, Salpietro V, Bello OD, Pope S, Pandraud A, Horga A, Scalco RS, Li A, Ashokkumar B, Lourenço CM, Heales S, Horvath R, Chinnery PF, Toro C, Singleton AB, Jacques TS, Abramov AY, Muntoni F, Hanna MG, Reilly MM, Revesz T, Kullmann DM, Jepson JEC, Houlden H.

Brain. 2017 Nov 1;140(11):2820-2837. doi: 10.1093/brain/awx231.

43.

Editorial.

Kullmann DM.

Brain. 2017 Sep 1;140(9):2253. doi: 10.1093/brain/awx210. No abstract available.

PMID:
29050403
44.

Editorial.

Kullmann DM.

Brain. 2017 May 1;140(5):1171. doi: 10.1093/brain/awx091. No abstract available.

PMID:
29050373
45.

Mutations in Membrin/GOSR2 Reveal Stringent Secretory Pathway Demands of Dendritic Growth and Synaptic Integrity.

Praschberger R, Lowe SA, Malintan NT, Giachello CNG, Patel N, Houlden H, Kullmann DM, Baines RA, Usowicz MM, Krishnakumar SS, Hodge JJL, Rothman JE, Jepson JEC.

Cell Rep. 2017 Oct 3;21(1):97-109. doi: 10.1016/j.celrep.2017.09.004.

46.

Editorial.

Kullmann DM.

Brain. 2017 Oct 1;140(10):2521. doi: 10.1093/brain/awx238. No abstract available.

PMID:
28969395
47.

Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.

Rosenow F, van Alphen N, Becker A, Chiocchetti A, Deichmann R, Deller T, Freiman T, Freitag CM, Gehrig J, Hermsen AM, Jedlicka P, Kell C, Klein KM, Knake S, Kullmann DM, Liebner S, Norwood BA, Omigie D, Plate K, Reif A, Reif PS, Reiss Y, Roeper J, Ronellenfitsch MW, Schorge S, Schratt G, Schwarzacher SW, Steinbach JP, Strzelczyk A, Triesch J, Wagner M, Walker MC, von Wegner F, Bauer S.

Epilepsy Behav. 2017 Nov;76:13-18. doi: 10.1016/j.yebeh.2017.06.041. Epub 2017 Sep 13. Review.

PMID:
28917501
48.

Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.

Bauer S, van Alphen N, Becker A, Chiocchetti A, Deichmann R, Deller T, Freiman T, Freitag CM, Gehrig J, Hermsen AM, Jedlicka P, Kell C, Klein KM, Knake S, Kullmann DM, Liebner S, Norwood BA, Omigie D, Plate K, Reif A, Reif PS, Reiss Y, Roeper J, Ronellenfitsch MW, Schorge S, Schratt G, Schwarzacher SW, Steinbach JP, Strzelczyk A, Triesch J, Wagner M, Walker MC, von Wegner F, Rosenow F.

Epilepsy Behav. 2017 Nov;76:7-12. doi: 10.1016/j.yebeh.2017.06.040. Epub 2017 Sep 14. Review.

PMID:
28917498
49.

Editorial.

Kullmann DM.

Brain. 2017 Aug 1;140(8):2065. doi: 10.1093/brain/awx183. No abstract available.

PMID:
28899027
50.

Focal cortical seizures start as standing waves and propagate respecting homotopic connectivity.

Rossi LF, Wykes RC, Kullmann DM, Carandini M.

Nat Commun. 2017 Aug 9;8(1):217. doi: 10.1038/s41467-017-00159-6.

Supplemental Content

Loading ...
Support Center